Personalis Inc. (PSNL)
NASDAQ
Closed
Oct 9, 2026
Day's Range
15.9752 wk Range
4.96Overview - PSNL - Personalis Inc.
Key Statistics
Valuation
Enterprise Value
1.58B
P/E (Trailing)
‪-18.07‬
P/E (Forward)
‪-17.48‬
PEG Ratio
‪-0.59‬
Price / Sales (TTM)
‪25.23‬
Price / Book
‪7.44‬
EV / EBITDA
‪-15.13‬
Profitability
Gross Margin
‪21.21%‬
Profit Margin
‪-153.83%‬
Operating Margin
‪-150.24%‬
Return on Assets
‪-25.03%‬
Return on Equity
‪-50.32%‬
Ownership
Shares Outstanding
106.36M
Float
86.37M
Short % of Shares Outstanding
‪12.09%‬
Held by Insiders
‪26.14%‬
Held by Institutions
‪66.78%‬
Price stats
Beta
‪2.31‬
50-Day Avg
‪15.09‬
200-Day Avg
‪10.31‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
5 analysts
Average price target
‪$ 15.44‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - PSNL - Personalis Inc.
Peers - PSNL - Personalis Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on NASDAQ.
- PSNLNASDAQPersonalis Inc.1.75BMarket Cap+61.42%52-week change-18.08P/E (Trailing)‪-153.83%‬Profit Margin
- NTRANASDAQNatera, Inc.59.14BMarket Cap+58.48%52-week change-269.84P/E (Trailing)‪-7.10%‬Profit Margin
- ILMNNASDAQIllumina Inc.41.22BMarket Cap+63.00%52-week change50.85P/E (Trailing)‪18.33%‬Profit Margin
- IDXXNASDAQIDEXX Laboratories, Inc.40.83BMarket Cap-21.10%52-week change37.14P/E (Trailing)‪25.03%‬Profit Margin
- GHNASDAQGuardant Health Inc.23.86BMarket Cap+64.35%52-week change-53.55P/E (Trailing)‪-38.32%‬Profit Margin
- MEDPNASDAQMedpace Holdings, Inc.16.86BMarket Cap+14.16%52-week change35.48P/E (Trailing)‪17.66%‬Profit Margin
- ICLRNASDAQICON plc12.50BMarket Cap-17.51%52-week change170.58P/E (Trailing)‪0.32%‬Profit Margin
Profile Summary - PSNL - Personalis Inc.
About
Personalis Inc. is a biotechnology company focused on advanced cancer genomics and precision oncology. Personalis develops and markets genomic tests and sequencing services that help healthcare providers, pharmaceutical companies, biopharma partners, universities, and government organizations analyze tumor and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
